BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 19379216)

  • 1. Survival analysis of one versus two treatments of local delivery cisplatin in a biodegradable polymer for canine osteosarcoma.
    Mehl ML; Seguin B; Dernell WS; Lafferty M; Kass PH; Withrow SJ
    Vet Comp Oncol; 2005 Jun; 3(2):81-6. PubMed ID: 19379216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
    Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
    Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracavitary treatment of soft tissue sarcomas in dogs using cisplatin in a biodegradable polymer.
    Dernell WS; Withrow SJ; Straw RC; Powers BE; Drekke JH; Lafferty M
    Anticancer Res; 1997; 17(6D):4499-505. PubMed ID: 9494558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in canine osteosarcoma.
    Kow K; Bailey SM; Williams ES; Withrow S; Lana SE
    Vet Comp Oncol; 2006 Sep; 4(3):184-7. PubMed ID: 19754815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative-intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: a preliminary retrospective evaluation of 14 dogs with the disease.
    Walter CU; Dernell WS; LaRue SM; Lana SE; Lafferty MH; LaDue TA; Withrow SJ
    Vet Comp Oncol; 2005 Mar; 3(1):1-7. PubMed ID: 19379208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow release cisplatin combined with radiation for the treatment of canine nasal tumors.
    Lana SE; Dernell WS; LaRue SM; Lafferty MJ; Douple EB; Brekke JH; Withrow SJ
    Vet Radiol Ultrasound; 1997; 38(6):474-8. PubMed ID: 9402717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment with locally delivered OncoGel delays the onset of paresis after surgical resection of experimental spinal column metastasis.
    Gok B; McGirt MJ; Sciubba DM; Garces-Ambrossi G; Nelson C; Noggle J; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL
    Neurosurgery; 2009 Jul; 65(1):193-9; discussion 199-200. PubMed ID: 19574842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for canine appendicular osteosarcoma.
    Coomer A; Farese J; Milner R; Liptak J; Bacon N; Lurie D
    Vet Comp Oncol; 2009 Mar; 7(1):15-27. PubMed ID: 19222827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-operative cisplatin for the treatment of canine extremity soft tissue sarcomas.
    Havlicek M; Straw RS; Langova V; Dernell WS
    Vet Comp Oncol; 2009 Jun; 7(2):122-9. PubMed ID: 19453366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
    De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
    J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997-2004).
    Camps-Palau MA; Leibman NF; Elmslie R; Lana SE; Plaza S; McKnight JA; Risbon R; Bergman PJ
    Vet Comp Oncol; 2007 Sep; 5(3):156-67. PubMed ID: 19754787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
    Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
    Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative radiotherapy and mitoxantrone for anal sac adenocarcinoma in the dog: 15 cases (1991-2001).
    Turek MM; Forrest LJ; Adams WM; Helfand SC; Vail DM
    Vet Comp Oncol; 2003 Jun; 1(2):94-104. PubMed ID: 19379321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
    London CA; Malpas PB; Wood-Follis SL; Boucher JF; Rusk AW; Rosenberg MP; Henry CJ; Mitchener KL; Klein MK; Hintermeister JG; Bergman PJ; Couto GC; Mauldin GN; Michels GM
    Clin Cancer Res; 2009 Jun; 15(11):3856-65. PubMed ID: 19470739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal wound healing/regeneration following implantation of recombinant human growth/differentiation factor-5 (rhGDF-5) in an absorbable collagen sponge carrier into one-wall intrabony defects in dogs: a dose-range study.
    Kim TG; Wikesjö UM; Cho KS; Chai JK; Pippig SD; Siedler M; Kim CK
    J Clin Periodontol; 2009 Jul; 36(7):589-97. PubMed ID: 19538332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008).
    Marconato L; Romanelli G; Stefanello D; Giacoboni C; Bonfanti U; Bettini G; Finotello R; Verganti S; Valenti P; Ciaramella L; Zini E
    J Am Vet Med Assoc; 2009 Oct; 235(8):967-72. PubMed ID: 19827983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNM stage is the most important determinant of survival in metachronous lung cancer.
    Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
    Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
    Taylor F; Gear R; Hoather T; Dobson J
    J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.